Skip to main content
. 2018 May 29;21(1):115–124. doi: 10.1093/neuonc/noy093

Fig. 3.

Fig. 3

Box-plots of total scores for each molecular subgroup in the SHH-specific nomogram. Note the significant difference in the mean scores for SHH-pathway medulloblastoma versus other subgroups in training cohort (A) as well as validation cohort (B). Receiver operating characteristic (ROC) curves derived using SHH-specific nomograms demonstrate excellent accuracy of predicting SHH-pathway medulloblastoma in both the training cohort (C) and the validation cohort (D).